Careers
Contact
Home
About Raptor
Products
Science & Technology
Partnering
Patients & Caregivers
Investors & Media
Overview
Corporate Governance
SEC Filings
Stock Performance
Financial Reports
News & Events
Investor FAQs
Presentations
Investor Contacts
Annual Report
Annual Report on Form 8-K For the Year Ended August 31, 2009
Raptor listed on NASDAQ Capital Market on September 30, 2009
Investor Toolkit
Print Page
Email Page
RSS Feeds
Email Alerts
SEC Filings
Form S-8
Raptor Pharmaceutical Corp filed this
Form S-8
on 05/14/10
Document Outline
Entire Document (461.6 KB)
Subdocument 1 - S-8 - RAPTOR S-8 051310
Page 1 - As filed with the Securities and Exchange Commission on May 14, 2010
Page 2 - PART I
Page 3 - N/A
Page 4 - ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Page 5 - ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.
Page 6 - ITEM 9. UNDERTAKINGS.
Page 7 - SIGNATURES
Page 8 - EXHIBIT INDEX
Subdocument 2 - EX-4.12 - RAPTOR 2010 STOCK INCENTIVE PLAN
Page 1 - RAPTOR PHARMACEUTICAL CORP.
Page 2 - Appendix I: Definitions
Page 3 - RAPTOR PHARMACEUTICAL CORP.
Page 4 - N/A
Subdocument 3 - EX-4.13 - RAPTOR FORM OF STOCK OPTION AWARD AGREEMENT
Page 1 - N/A
Page 2 - RAPTOR PHARMACEUTICAL CORP.
Page 3 - Exhibit A
Page 4 - Exhibit B
Page 5 - Exhibit C
Page 6 - Exhibit D
Page 7 - N/A
Subdocument 4 - EX-5.1 - LEGAL OPINION
Page 1 - Exhibit 5.1
Page 2 - N/A
Subdocument 5 - EX-23.1 - AUDITOR CONSENT
Page 1 - Exhibit 23.1
Page 2 - N/A